Fig 1: Kaplan–Meier survival curves according to cytoplasmic HDAC-4 positivity in serous carcinomas.
Fig 2: Immunohistochemical expression of HDAC-2 (A,D), HDAC-4 (B,E), and HDAC-5 (C,F) in epithelial ovarian carcinomas. (A) A high-grade serous ovarian carcinoma with nuclear HDAC-2 expression (×200). (B) A high-grade serous ovarian carcinoma with cytoplasmic HDAC-4 expression (×200). (C) A high-grade serous ovarian carcinoma with cytoplasmic HDAC-5 expression (×400). (D) A high-grade serous ovarian carcinoma with nuclear HDAC-2 expression (×400). (E) A high-grade serous ovarian carcinoma with cytoplasmic HDAC-4 expression (×400). (F) A high-grade serous ovarian carcinoma with nuclear and cytoplasmic HDAC-4 expression (×400).
Supplier Page from Abcam for Anti-HDAC4 antibody